Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma R HájekAW Butch Review 01 February 2000 Pages: 2 - 15
Myelodysplasia and apoptosis: new insights into ineffective erythropoiesis AA van de LoosdrechtE Vellenga Review 01 February 2000 Pages: 16 - 21
C-erb-B2 expression and response to treatment in metastatic breast cancer W R Bezwoda Original Paper 01 February 2000 Pages: 22 - 28
Serum erythropoietin level in anemic cancer patients M OzgurogluB ArunB Berkarda Original Paper 01 February 2000 Pages: 29 - 34
Seropositivity for MIA and S100 in patients with gastrointestinal carcinomas V WagnerJ RudiW Stremmel Original Paper 01 February 2000 Pages: 35 - 38
Adding high-dose tamoxifen to CHOP does not influence response or survival in aggressive non-Hodgkin's lymphoma: an interim analysis of a randomized phase III trial A A EzzatE M IbrahimJohn Berry Original Paper 01 February 2000 Pages: 39 - 46
Phase II study of etoposide (VP-16) in patients with thyroid cancer with no prior chemotherapy: an Eastern Cooperative Oncology Group Study (E1385) AN LeafBC WolfRE Haselow Original Paper 01 February 2000 Pages: 47 - 51
Induction of matric metalloprotease-7 is common in mucinous ovarian tumors including early stage disease K ShigemasaH TanimotoTJ O'Brien Original Paper 01 February 2000 Pages: 52 - 58
Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in hodgkin's disease, the Milan Cancer Institute Experience S. VivianiP NottiG Bonadonna Original Paper 01 February 2000 Pages: 59 - 63
Dermatomyositis after interferon alpha treatment LL DietrichAJ BridgesMR Albertini Case Report 01 February 2000 Pages: 64 - 69
Campath-1H in B-chronic lymphocytic leukemia: report on a patient treated thrice in a 3 year period GA PangalisMN DimopoulouMP Siakantaris Case Report 01 February 2000 Pages: 70 - 73
Primary eyelid plasmacytoma L OlivieriM Di IanniA Tabilio Case Report 01 February 2000 Pages: 74 - 75